Skip to main content
. 2021 Nov 10;9(3):e01162-21. doi: 10.1128/Spectrum.01162-21

FIG 1.

FIG 1

Levels of SARS CoV-2 IgG against the spike protein’s receptor-binding domain by vaccine brand (BNT162b2, mRNA-1273) and over time following the first and second doses.